A Clinical Study on the Safety and Efficacy of GP681 Tablets in the Treatment of Uncomplicated Acute Influenza
Clinical trial NCT04736758 · COMPLETED
Trial details
- NCT number
- NCT04736758
- Sponsor
- Jiangxi Qingfeng Pharmaceutical Co. Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-08
- Primary completion
- 2021-12-18
- Enrollment
- 216
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.